欢迎您注册蒲公英
您需要 登录 才可以下载或查看,没有帐号?立即注册
x
Investigating Out-ofSpecification (OOS) Test
Results for
Pharmaceutical Production
Guidance for Industry
Additional copies are available from:
Office of Communications, Division of Drug Information
Center for Drug Evaluation and Research
Food and Drug Administration
10001 New Hampshire Ave., Hillandale Bldg., 4th Floor
Silver Spring, MD 20993-0002
Phone: 855-543-3784 or 301-796-3400; Fax: 301-431-6353
Email: druginfo@fda.hhs.gov
https://www.fda.gov/drugs/guidance-compliance-regulatory-information/guidances-drugs
U.S. Department of Health and Human Services
Food and Drug Administration
Center for Drug Evaluation and Research (CDER)
May 2022
Pharmaceutical Quality/Manufacturing Standards
Current Good Manufacturing Practice (CGMP)
更多副本可向以下单位索取 药品信息部通信办公室 药品评价和研究中心 食品和药品管理局 10001 New Hampshire Ave., Hillandale Bldg., 4th Floor 马里兰州银泉,20993-0002 电话:855-543-3784或301-796-3400;传真:301-431-6353 电子邮件:druginfo@fda.hhs.gov https://www.fda.gov/drugs/guidance-compliance-regulatory-information/guidances-drugs 美国卫生与公众服务部 食品和药品管理局 药品评估和研究中心(CDER) 2022年5月 药品质量/制造标准 现行良好生产规范(CGMP)
|